相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Anti-PD-1/PD-L1 therapy of human cancer: past, present, and future
Lieping Chen et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
Stephen M. Ansell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
J. Larkin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
PD-1 Blockade Can Restore Functions of T-Cells in Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma In Vitro
Lina Quan et al.
PLOS ONE (2015)
Effector lymphocyte-induced lymph node-like vasculature enables naive T-cell entry into tumours and enhanced anti-tumour immunity
J. David Peske et al.
NATURE COMMUNICATIONS (2015)
Update on checkpoint blockade therapy for lymphoma
Justin Kline et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2015)
LMP1-deficient Epstein-Barr virus mutant requires T cells for lymphomagenesis
Shi-Dong Ma et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Host genetics of Epstein-Barr virus infection, latency and disease
Charlotte J. Houldcroft et al.
REVIEWS IN MEDICAL VIROLOGY (2015)
Biochemical Signaling of PD-1 on T Cells and Its Functional Implications
Vassiliki A. Boussiotis et al.
CANCER JOURNAL (2014)
Checkpoint blocking antibodies in cancer immunotherapy
Chrisann Kyi et al.
FEBS LETTERS (2014)
The interplay between Epstein-Barr virus and B lymphocytes: implications for infection, immunity, and disease
Olivia L. Hatton et al.
IMMUNOLOGIC RESEARCH (2014)
Survival, Durable Tumor Remission, and Long-Term Safety in Patients With Advanced Melanoma Receiving Nivolumab
Suzanne L. Topalian et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Comprehensive molecular characterization of gastric adenocarcinoma
Adam J. Bass et al.
NATURE (2014)
Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing
Mahesh Yadav et al.
NATURE (2014)
Somatic Mutations and Immunotherapy Outcome with CTLA-4 Blockade in Melanoma
Vassiliki A. Boussiotis
NEW ENGLAND JOURNAL OF MEDICINE (2014)
EBV-driven LMP1 and IFN-γ up-regulate PD-L1 in nasopharyngeal carcinoma: Implications for oncotargeted therapy
Wenfeng Fang et al.
ONCOTARGET (2014)
Immunological Dysregulation in Multiple Myeloma Microenvironment
Alessandra Romano et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Holoendemic Malaria Exposure Is Associated with Altered Epstein-Barr Virus-Specific CD8+ T-Cell Differentiation
Pratip K. Chattopadhyay et al.
JOURNAL OF VIROLOGY (2013)
Innate and adaptive immune cells in the tumor microenvironment
Thomas F. Gajewski et al.
NATURE IMMUNOLOGY (2013)
Safety and Tumor Responses with Lambrolizumab (Anti-PD-1) in Melanoma
Omid Hamid et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Lymphomas occurring specifically in HIV-infected patients: From pathogenesis to pathology
Annunziata Gloghini et al.
SEMINARS IN CANCER BIOLOGY (2013)
Spontaneous Lytic Replication and Epitheliotropism Define an Epstein-Barr Virus Strain Found in Carcinomas
Ming-Han Tsai et al.
CELL REPORTS (2013)
Peripheral tissue homing receptor control of naive, effector, and memory CD8 T cell localization in lymphoid and non-lymphoid tissues
C. Colin Brinkman et al.
FRONTIERS IN IMMUNOLOGY (2013)
Constitutive AP-1 Activity and EBV Infection Induce PD-L1 in Hodgkin Lymphomas and Posttransplant Lymphoproliferative Disorders: Implications for Targeted Therapy
Michael R. Green et al.
CLINICAL CANCER RESEARCH (2012)
EBNA3B-deficient EBV promotes B cell lymphomagenesis in humanized mice and is found in human tumors
Robert E. White et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
B7-H1, Which Represses EBV-Immortalized B Cell Killing by Autologous T and NK Cells, Is Oppositely Regulated by c-Myc and EBV Latency III Program at Both mRNA and Secretory Lysosome Levels
Stephanie Durand-Panteix et al.
JOURNAL OF IMMUNOLOGY (2012)
Early Age at Time of Primary Epstein-Barr Virus Infection Results in Poorly Controlled Viral Infection in Infants From Western Kenya: Clues to the Etiology of Endemic Burkitt Lymphoma
Erwan Piriou et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
An Epstein-Barr Virus (EBV) Mutant with Enhanced BZLF1 Expression Causes Lymphomas with Abortive Lytic EBV Infection in a Humanized Mouse Model
Shi-Dong Ma et al.
JOURNAL OF VIROLOGY (2012)
Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer
Suzanne L. Topalian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Hodgkin Lymphoma in Patients with HIV Infection: A Review
Nihal Martis et al.
CURRENT HEMATOLOGIC MALIGNANCY REPORTS (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
Lymphomas differ in their dependence on Epstein-Barr virus
David T. Vereide et al.
BLOOD (2011)
Expression of PD-L1 and PD-L2 on human macrophages is up-regulated by HIV-1 and differentially modulated by IL-10
Marta Rodriguez-Garcia et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2011)
A prospective phase II trial exploring the association between tumor microenvironment biomarkers and clinical activity of ipilimumab in advanced melanoma
Omid Hamid et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2011)
A New Model of Epstein-Barr Virus Infection Reveals an Important Role for Early Lytic Viral Protein Expression in the Development of Lymphomas
Shi-Dong Ma et al.
JOURNAL OF VIROLOGY (2011)
Exhausted Cytotoxic Control of Epstein-Barr Virus in Human Lupus
Martin Larsen et al.
PLOS PATHOGENS (2011)
Novel cancer immunotherapy agents with survival benefit: recent successes and next steps
Padmanee Sharma et al.
NATURE REVIEWS CANCER (2011)
The interplay between Epstein-Barr virus and the immune system: a rationale for adoptive cell therapy of EBV-related disorders
Anna Merlo et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Age-related Epstein-Barr virus (EBV)-associated B-cell lymphoproliferative disorders: comparison with EBV-positive classic Hodgkin lymphoma in elderly patients
Naoko Asano et al.
BLOOD (2009)
HIV-associated lymphomas and gamma-herpesviruses
Antonino Carbone et al.
BLOOD (2009)
Priming of protective T cell responses against virus-induced tumors in mice with human immune system components
Till Strowig et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Cyclical Expression of EBV Latent Membrane Protein 1 in EBV-Transformed B Cells Underpins Heterogeneity of Epitope Presentation and CD8+ T Cell Recognition
Jill M. Brooks et al.
JOURNAL OF IMMUNOLOGY (2009)
T Cell-Mediated Control of Epstein-Barr Virus Infection in Humanized Mice
Misako Yajima et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
EBV latent membrane proteins (LMPs) 1 and 2 as immunotherapeutic targets:: LMP-specific CD4+ cytotoxic T cell recognition of EBV-transformed B cell lines
Tracey A. Haigh et al.
JOURNAL OF IMMUNOLOGY (2008)
Molecular basis of cytotoxicity of Epstein-Barr virus (EBV) latent membrane protein 1 (LMP1) in EBV latency IIIB cells: LMP1 induces type II ligand-independent autoactivation of CD95/Fas with caspase 8-mediated apoptosis
Christophe Le Clorennec et al.
JOURNAL OF VIROLOGY (2008)
Immunodominance of Lytic Cycle Antigens in Epstein-Barr Virus-Specific CD4+T Cell Preparations for Therapy
Dinesh Adhikary et al.
PLOS ONE (2007)
Enhanced NFATc1 nuclear occupancy causes T cell activation independent of CD28 costimulation
Minggui Pan et al.
JOURNAL OF IMMUNOLOGY (2007)
Increase in circulating Foxp3+CD4+CD25 high regulatory T cells in nasopharyngeal carcinoma patients
K-M Lau et al.
BRITISH JOURNAL OF CANCER (2007)
被撤回的出版物: Transactivation of the CCL5/RANTES gene by Epstein-Barr virus latent membrane protein (Retracted article. See vol. 129, pg. 2762, 2011)
JN Uchihara et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Outcome in Hodgkin's lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells
T Alvaro et al.
CLINICAL CANCER RESEARCH (2005)
Self-inhibition of synthesis and antigen presentation by Epstein-Barr virus-encoded EBNA1
Y Yin et al.
SCIENCE (2003)
Regulatory T cells secreting IL-10 dominate the immune response to EBV latent membrane protein 1
NA Marshall et al.
JOURNAL OF IMMUNOLOGY (2003)
Generating CTLs against the subdominant Epstein-Barr virus LMP1 antigen for the adoptive immunotherapy of EBV-associated malignancies
S Gottschalk et al.
BLOOD (2003)
T-cell regulation by CD28 and CTLA-4
ML Alegre et al.
NATURE REVIEWS IMMUNOLOGY (2001)
分享论文
